Savient shares soar on FDA gout treatment approval - MarketWatch

Health Jackal

Savient shares soar on FDA gout treatment approval MarketWatch The FDA approved Savient's Krystexxa for the treatment of hard-to-treat gout in adults. Gout is a type of arthritis where uric acid crystallizes in the ... FDA approves gout treatment from SavientDrug Store News FDA Approves Krystexxa, New Treatment for GoutDrugWatch.com Savient's Krystexxa Approved by FDA for Treatment of GouteMaxHealth BusinessWeek -Reuters -Wall Street Journal all 204 news articles »

BioCryst Drug Boosted Existing Gout Treatment In Study - Wall Street Journal

BioCryst Drug Boosted Existing Gout Treatment In Study Wall Street Journal The study showed the combination of BCX4208 and gout-treatment allopurinol reduced serum uric acid concentration more than either drug alone. ... BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined ...MarketWatch (press release) BioCryst gout drug shows promise in mid-stage trialReuters BioCryst Pharma Reports Positive Results From Phase 2 Study Of Gout Drug - UpdateStock Markets Review Birmingham Business Journal all 37 news articles »

FDA Approves New Gout Treatment Krystexxa - RTT News

RTT News

FDA Approves New Gout Treatment Krystexxa RTT News "Krystexxa is the first-ever and only treatment approved by the FDA for adult patients who suffer with chronic gout that is refractory to conventional ... Savient shares Shares at a 52 week high following chatterSmall Cap Network Rumor Mill Sends Savient Pharma (SVNT) Shares SoaringStreetInsider.com (subscription) (blog) Stock Rumors of the Day (Savient Pharmaceuticals, Brocade Communications , IBM)Emailwire (press release) all 21 news articles »

Dr. Donohue: Whooping cough - Richmond Times Dispatch

Dr. Donohue: Whooping cough Richmond Times Dispatch My uncle has gout and diabetes. Can you have gout without having diabetes? What should I do? -- JP DEAR JP: At your next attack, you should go to a doctor ... and more »